Category: CBSA News

Weekly Policy Update: President Biden Signs New Drug Pricing Executive Order

By: Colorado BioScience Association   Date: 10/21/2022

President Biden signed an Executive Order on Friday, October 14th directing Health and Human Services (HHS) to explore additional actions to lower prescription drug costs. This order is on top of...

Learn More

Weekly Policy Blog: CBSA Engages on Transitional Coverage for Emerging Technologies (TCET)

By: Colorado BioScience Association   Date: 10/14/2022

The Centers for Medicare & Medicaid Services (CMS) are currently working to develop a new rule that could provide Medicare patients faster access to innovative, lifesaving, and life-enhancing medi...

Learn More

Weekly Policy Blog: CBSA Continues Engagement on the WTO TRIPS Waiver

By: Colorado BioScience Association   Date: 10/07/2022

In a few months, member states of the World Trade Organization (WTO) will decide whether to expand the TRIPS waiver to include COVID-19 therapeutics and diagnostics. Colorado BioScience Association is...

Learn More

Victories for Innovation: Congress Reauthorizes the SBIR/STTR and User Fee Programs

By: Colorado BioScience Association   Date: 09/30/2022

CBSA celebrates policy victories for Colorado's life sciences community and America’s innovators, scientists, and entrepreneurs. Congress reauthorized critical SBIR/STTR and User Fee programs. Without...

Learn More

Fitzsimons Innovation Community Companies Demonstrate Momentum

By: Colorado BioScience Association   Date: 09/23/2022

Fitzsimons Innovation Community has been a partner of the Rocky Mountain Life Sciences Investor & Partnering Conference since its inception, recognizing the importance of this gathering to showcas...

Learn More

Weekly Update: Biden Administration Cancer Moonshot Initiative; Bi-Partisan Majority Support in Congress - Multi-Cancer Early Detection Screening Coverage Act (S.1873/ H.R. 1946)

By: Colorado BioScience Association   Date: 09/23/2022

President Biden’s Cancer Moonshot Initiative On the 60th anniversary of President Kennedy’s “We Choose to Go to the Moon” speech, President Biden gave an update on his Cancer Moonshot Initiative, whic...

Learn More

CBSA Remains Active on the Critical Need to Reauthorize Vital SBIR/STTR Programs for Life Sciences

By: Colorado BioScience Association   Date: 09/16/2022

Act Today and Tell Your Member of Congress to Support Vital SBIR/STTR Programs for Life Sciences The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs ar...

Learn More

Weekly Policy Blog: Colorado BioScience Political Action Committee Fuels Policy + Advocacy Engagement and Impact

By: Colorado BioScience Association   Date: 09/09/2022

The Colorado BioScience Political Action Committee (CBSA PAC), a bipartisan state political action committee, provides opportunities to educate candidates for the state legislature about our life scie...

Learn More

Colorado BioScience Association Announces Record-Breaking Attendance at Vail Investor Conference

By: Colorado BioScience Association   Date: 09/06/2022

Rocky Mountain Life Sciences Investor & Partnering Conference to Welcome More than 200 Attendees Denver – Colorado BioScience Association (CBSA) will highlight the future of health innovation at t...

Learn More

Weekly Policy Blog: August Prescription Drug Affordability Review Board (PDAB) Meeting

By: Colorado BioScience Association   Date: 09/02/2022

On August 26, CBSA and our partners participated in the state Prescription Drug Affordability Review Board (PDAB) meeting, which was open to the public. The PDAB was created in 2021 when the state leg...

Learn More